Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06580860

Psychiatric Multi-omics and Neuroimaging Project

Psychiatric Multi-omics and Neuroimaging Project Database

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,899 (estimated)
Sponsor
mingjun Zhong · Academic / Other
Sex
All
Age
13 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.

Detailed description

The study seeks to identify possible biological markers of schizophrenia and the effects of gene-environment interactions on brain structural and functional networks. So we can help doctors and scientific researchers better understand the neuropathological basis of schizophrenia.

Conditions

Interventions

TypeNameDescription
DRUGAntipsychotic drugs, antidepressants, mood stabilizers, and sleep aidsPatients with mental disorders should take the appropriate medicine as prescribed by the doctor,and the health norms are not required to take medicine.This study will not interfere with the medication regimen of doctors.

Timeline

Start date
2016-01-01
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2024-08-30
Last updated
2026-03-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06580860. Inclusion in this directory is not an endorsement.

Psychiatric Multi-omics and Neuroimaging Project (NCT06580860) · Clinical Trials Directory